Skip to main content
Shehabaldin Alqalyoobi, MD, Pulmonology, Greenville, NC, ECU Health Medical Center

ShehabaldinAlqalyoobiMD

Pulmonology Greenville, NC

Critical Care Medicine, Interstitial Lung Diseases

Assistant Professor of Medicine

Dr. Alqalyoobi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Alqalyoobi's full profile

Already have an account?

Education & Training

  • University of Louisville
    University of LouisvilleMS, Biostatistics, 2020 - 2023
  • University of California Davis Health
    University of California Davis HealthFellowship, Pulmonary Disease and Critical Care Medicine, 2016 - 2019
  • University of Missouri-Kansas City School of Medicine
    University of Missouri-Kansas City School of MedicineResidency, Internal Medicine, 2013 - 2016
  • Arabian Gulf University College of Medicine
    Arabian Gulf University College of MedicineClass of 2009

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2019 - 2024
  • CA State Medical License
    CA State Medical License 2016 - 2019
  • MO State Medical License
    MO State Medical License 2013 - 2016
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Critical Care Medicine
  • American Board of Internal Medicine Pulmonary Disease
  • National Board of EchocardiographyCritical Care Echocardiography (Diplomate)

Awards, Honors, & Recognition

  • Outstanding Pulmonary disease faculty member of the year The Brody School of Medicine at East Carolina University, 2021
  • California Thoracic Society Scholar award California Thoracic Society, 2019
  • The American Federation for Medical Research Henry Christian Award American Federation for Medical Research, 2018
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • New Approved Medications for Idiopathic Pulmonary Fibrosis  
    Alqalyoobi S, Salzman G, Current Drug Therapy, 12/2015

Press Mentions

  • Plasma Biomarkers of Idiopathic Pulmonary Fibrosis May Predict Survival
    Plasma Biomarkers of Idiopathic Pulmonary Fibrosis May Predict SurvivalSeptember 26th, 2019

Professional Memberships

Hospital Affiliations